Russell Investments Group, Ltd. Emergent Bio Solutions Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 585 shares of EBS stock, worth $5,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares

585

Previous 4,778 87.76%

Holding current value

$5,422

Previous $32,000 87.5%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.72 - $14.77 $23,983 - $61,930	-4,193 Reduced 87.76%	585 $4,000
Q2 2024 Aug 08, 2024	BUY	$1.86 - $6.98 $6,867 - $25,770	3,692 Added 339.96%	4,778 $32,000
Q1 2024 May 08, 2024	SELL	$1.5 - $3.41 $132,463 - $301,133	-88,309 Reduced 98.79%	1,086 $2,000
Q4 2023 Feb 05, 2024	SELL	$1.82 - $3.16 $17,674 - $30,686	-9,711 Reduced 9.8%	89,395 $214,000
Q3 2023 Nov 13, 2023	SELL	$3.17 - $7.91 $183,885 - $458,843	-58,008 Reduced 36.92%	99,106 $336,000
Q2 2023 Aug 10, 2023	BUY	$7.35 - $13.21 $14,663 - $26,353	1,995 Added 1.29%	157,114 $1.15 Million
Q1 2023 May 09, 2023	SELL	$7.79 - $16.29 $301,028 - $629,494	-38,643 Reduced 19.94%	155,119 $1.61 Million
Q4 2022 Feb 08, 2023	BUY	$11.0 - $21.45 $444,290 - $866,365	40,390 Added 26.33%	193,762 $2.29 Million
Q3 2022 Nov 04, 2022	SELL	$20.09 - $35.8 $1.03 Million - $1.84 Million	-51,365 Reduced 25.09%	153,372 $3.22 Million
Q2 2022 Jul 29, 2022	BUY	$27.42 - $43.63 $3 Million - $4.77 Million	109,253 Added 114.42%	204,737 $6.35 Million
Q1 2022 May 05, 2022	BUY	$36.48 - $52.22 $2.51 Million - $3.59 Million	68,843 Added 258.41%	95,484 $3.92 Million
Q4 2021 Jan 21, 2022	SELL	$33.11 - $55.01 $1.64 Million - $2.72 Million	-49,469 Reduced 65.0%	26,641 $1.16 Million
Q3 2021 Nov 08, 2021	SELL	$50.07 - $66.05 $125,825 - $165,983	-2,513 Reduced 3.2%	76,110 $3.81 Million
Q2 2021 Aug 04, 2021	BUY	$56.61 - $80.46 $3.02 Million - $4.29 Million	53,295 Added 210.42%	78,623 $4.96 Million
Q1 2021 May 10, 2021	BUY	$86.23 - $125.19 $327,329 - $475,221	3,796 Added 17.63%	25,328 $2.35 Million
Q4 2020 Feb 08, 2021	BUY	$79.17 - $111.47 $17,259 - $24,300	218 Added 1.02%	21,532 $1.94 Million
Q3 2020 Nov 09, 2020	BUY	$81.91 - $134.94 $1.45 Million - $2.4 Million	17,756 Added 499.04%	21,314 $2.2 Million
Q2 2020 Aug 05, 2020	SELL	$54.33 - $89.52 $708,626 - $1.17 Million	-13,043 Reduced 78.57%	3,558 $278,000
Q1 2020 May 06, 2020	SELL	$49.34 - $68.76 $1.34 Million - $1.87 Million	-27,133 Reduced 62.04%	16,601 $909,000
Q4 2019 Jan 29, 2020	SELL	$51.21 - $59.06 $2.05 Million - $2.36 Million	-40,001 Reduced 47.77%	43,734 $2.37 Million
Q3 2019 Nov 01, 2019	SELL	$40.6 - $57.2 $990,112 - $1.39 Million	-24,387 Reduced 22.56%	83,735 $4.31 Million
Q2 2019 Aug 09, 2019	SELL	$39.92 - $53.86 $1.44 Million - $1.94 Million	-36,079 Reduced 25.02%	108,122 $5.2 Million
Q1 2019 May 13, 2019	SELL	$48.23 - $66.16 $1.88 Million - $2.59 Million	-39,082 Reduced 21.32%	144,201 $7.22 Million
Q4 2018 Feb 11, 2019	SELL	$55.63 - $73.24 $157,599 - $207,488	-2,833 Reduced 1.52%	183,283 $10.8 Million
Q3 2018 Oct 26, 2018	SELL	$52.05 - $66.51 $5.87 Million - $7.5 Million	-112,777 Reduced 37.73%	186,116 $12.2 Million
Q2 2018 Aug 08, 2018	SELL	$48.33 - $55.64 $13 Million - $14.9 Million	-268,149 Reduced 47.29%	298,893 $15.1 Million
Q1 2018 May 11, 2018	BUY	$44.44 - $54.39 $5.36 Million - $6.56 Million	120,684 Added 27.04%	567,042 $29.9 Million
Q4 2017 Feb 06, 2018	SELL	$37.77 - $47.75 $294,606 - $372,450	-7,800 Reduced 1.72%	446,358 $21.3 Million
Q3 2017 Nov 07, 2017	BUY	$34.14 - $40.45 $15.5 Million - $18.4 Million	454,158	454,158 $18.4 Million

Others Institutions Holding EBS

# of Institutions

158

Shares Held

32.9M

Call Options Held

424K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $462M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Emergent Bio Solutions Inc. Transaction History